| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5860601 | Toxicology Letters | 2013 | 7 Pages |
Abstract
- First detailed in vivo case study on human deoxynivalenol and zearalenone metabolism.
- Urinary excretion patterns were investigated over a period of eight days.
- A third deoxynivalenol-glucuronide isomer was tentatively identified for the first time in human urine.
- Fate of ingested masked DON forms in humans was preliminary investigated.
- Urinary excretion rate of total zearalenone was estimated.
Keywords
Deoxynivalenoldeoxynivalenol-glucuronideDON-GlcADeoxynivalenol-3-glucosideTDISCFJECFAdeoxynivalenol-3-glucuronideZEN3ADON3-acetyl-deoxynivalenolBiomarkerToxicokineticsDONZearalenonephase II metabolismJoint FAO/WHO Expert Committee on Food AdditivesTolerable daily intakeMycotoxinScientific Committee on FoodGlucuronide
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Benedikt Warth, Michael Sulyok, Franz Berthiller, Rainer Schuhmacher, Rudolf Krska,